Minority Diabetes Initiative Act
Latest Action
Referred to the House Committee on Energy and Commerce.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Minority Diabetes Initiative Act, introduced in the 118th Congress as H.R. 10193, is a health policy bill aimed at addressing diabetes within minority populations. The bill was referred to the House Committee on Energy and Commerce but did not advance further and ultimately failed or expired. No official summary or full text is available, limiting detailed analysis of its provisions. The bill falls under the health policy area and appears to focus on initiatives related to diabetes prevention, treatment, or research targeted at minority groups.
H.R. 10193 sought to address diabetes disparities among minority populations but did not progress beyond committee referral and expired without enactment.
- The bill is titled the Minority Diabetes Initiative Act and was introduced in the House of Representatives during the 118th Congress.
- It was referred to the House Committee on Energy and Commerce on November 21, 2024, but no further legislative action was recorded.
- The bill is categorized under the health policy area and aims to target diabetes issues affecting minority communities.
['Minority populations affected by diabetes', 'Healthcare providers and organizations focused on minority health', 'Federal health agencies involved in diabetes research and prevention']
['Lack of available full bill text and official summary limits understanding of specific provisions and implementation mechanisms.', 'Unclear funding sources and authorization of appropriations may affect feasibility and sustainability.', 'Absence of oversight or enforcement language in the available data raises questions about accountability.']
The bill was introduced in the House during the 118th Congress and referred to the House Committee on Energy and Commerce, a common committee for health-related legislation. The bill did not advance beyond referral and ultimately failed or expired, indicating it did not receive sufficient legislative support or priority to move forward. The focus on minority health aligns with ongoing congressional interest in addressing health disparities.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential increased focus on minority health disparities in diabetes if similar future legislation is introduced.', 'Possible influence on federal health agencies to prioritize diabetes-related programs for minority populations.', "Raised awareness among stakeholders about the need for targeted health initiatives, despite the bill's failure."]
The absence of an official summary and full bill text significantly limits transparency and public understanding of the Minority Diabetes Initiative Act. This lack of detailed information hinders effective oversight and evaluation of the bill's intended policy measures and resource allocations. Additionally, the bill's failure to progress beyond committee referral suggests limited legislative momentum, which is important context for assessing its impact.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.